Syndia v. Gillette
This article was originally published in The Rose Sheet
Executive Summary
Gillette ordered to pay Syndia $10 mil. in damages June 14 by jury in Chicago federal court in patent infringement case. Gillette's "diamond-like carbon"-coated razor blades used in Mach3, Mach3 Turbo and Venus razors found to infringe patents owned by Syndia, Chicago company maintains. Damages and injunctive relief for any future infringement have yet to be determined, Syndia adds, noting it intends to file for injunctive relief "barring future sales of March3, Turbo and Venus." Gillette said the ruling will have no material impact on business and does not prevent the firm from manufacturing any of its blades or razors. "Gillette also is prepared to appeal this matter to the Federal Circuit Court of Appeals in Washington, D.C. if that should prove necessary," company adds...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.